Abstract
The incidence of mammary tumours developing after administration of the carcinogen DMBA (at 50 days of age) has been determined in 2 strains of Sprague-Dawley rat. Untreated animals of each strain were exsanguinated in dioestrus at a time corresponding to the early post-carcinogen stage (at 70 days of age) and the plasma concentrations of prolactin, oestradiol-17B and progesterone were measured by radioimmunoassay. In an inbred strain of rats, tumour-induction rate was 6-4% and plasma prolactin concentration was 2-5 x lower than that found in a random-bred strain with a tumour-induction rate of 41-6%. No difference was found between the 2 strains in the level of either ovarian hormone. It is concluded that the difference between these strains in mammary gland susceptibility to DMBA may be related to plasma prolactin concentration, but it is unlikely to be determined by the ovarian hormones.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Hawkins, R., Drewitt, D., Freedman, B. et al. Plasma hormone levels and the incidence of carcinogen-induced mammary tumours in two strains of rat. Br J Cancer 34, 546–549 (1976). https://doi.org/10.1038/bjc.1976.209
Issue Date:
DOI: https://doi.org/10.1038/bjc.1976.209
This article is cited by
-
Pineal melatonin inhibition of tumor promotion in theN-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo
Journal of Cancer Research and Clinical Oncology (1991)
-
Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors
Breast Cancer Research and Treatment (1984)
-
Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17β
Breast Cancer Research and Treatment (1984)